 |
 |
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Oct 20, 2021 |
Title |
A single-cell epigenetic atlas of human IDH-mutant glioma |
Organisms |
Homo sapiens; Mus musculus |
Experiment type |
Genome binding/occupancy profiling by high throughput sequencing Expression profiling by high throughput sequencing
|
Summary |
Recent single-cell transcriptomic studies report that IDH-mutant gliomas share a common hierarchy of cellular phenotypes, independent of genetic subtype. However, the genetic differences between IDH-mutant glioma subtypes are prognostic, predictive of response to chemotherapy, and correlate with distinct tumor microenvironments. To reconcile these findings, we profiled 22 human IDH-mutant gliomas via single-cell assay for transposase-accessible chromatin (scATAC-seq). We determined the cell-type specific differences in transcription-factor expression and associated regulatory grammars between IDH-mutant glioma subtypes. We find that while IDH-mutant gliomas do share a common distribution of cell types, there are significant differences in the expression and targeting of transcription factors that regulate glial identity and cytokine elaboration. We knocked out the chromatin-remodeler ATRX, which suffers loss-of-function alterations in most IDH-mutant astrocytomas, in an IDH-mutant immunocompetent intracranial murine model. We find that both human ATRX-mutant gliomas and murine ATRX-knockout gliomas are more heavily infiltrated by immunosuppressive monocytic-lineage cells derived from circulation than ATRX-intact gliomas, in an IDH-mutant background. ATRX knockout in murine glioma recapitulates gene expression and open-chromatin signatures that are specific to human ATRX-mutant astrocytomas, including drivers of astrocytic lineage and immune-cell chemotaxis. ATRX knockout in murine glioma recapitulates gene expression and open chromatin signatures that are specific to human ATRX-mutant astrocytomas, including drivers of astrocytic lineage and immune-cell chemotaxis. Through single-cell cleavage under targets and tagmentation assays and meta-analysis of public data, we show that ATRX loss leads to a global depletion in CCCTC-binding factor association with DNA, gene dysregulation along associated chromatin loops, and protection from therapy-induced senescence.
|
|
|
Overall design |
We profiled specimens from 22 grade-II/III IDH-mutant untreated human gliomas via single-cell assay for transposase-accessible chromatin (scATAC-seq). We profiled murine IDH1R132H+/ATRX-KO and IDH1R132H/ATRX-intact gliomas via scATAC-seq, snRNA-seq, and anti-CTCF snCUT&Tag. *** Raw data not available due to privacy concerns.
|
|
|
Contributor(s) |
Babikir H, Wang L, Shamardani K, Catalan F, Sudhir S, Aghi MK, Raleigh D, Phillips JJ, Diaz AA |
Citation(s) |
34763709 |
|
Submission date |
Jul 30, 2020 |
Last update date |
May 16, 2022 |
Contact name |
Aaron Diaz |
E-mail(s) |
aaron.diaz@ucsf.edu
|
Organization name |
University of California, San Francisco
|
Department |
Neurological Surgery
|
Lab |
Diaz Lab
|
Street address |
1450 3rd St
|
City |
San Francisco |
State/province |
CA |
ZIP/Postal code |
94158 |
Country |
USA |
|
|
Platforms (2) |
GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
Samples (23)
|
|
Relations |
BioProject |
PRJNA649750 |
Supplementary file |
Size |
Download |
File type/resource |
GSE155430_RAW.tar |
270.1 Mb |
(http)(custom) |
TAR (of BED, MTX, TSV, TXT) |
Processed data provided as supplementary file |
Raw data not provided for this record |
|
|
|
|
 |